Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
Neuro-Oncology
|
February 18, 2020
"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas
Rajan Jain, Derek R Johnson, Sohil H Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor
Andrew S Chi, Tracy T Batchelor, Eunice L Kwak, et al.
Journal of Neuro-Oncology
|
November 5, 2015
Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
Brian V Nahed, Navid Redjal, Daniel J Brat, et al.
Circulation Research
|
July 29, 2006
Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling
Stephanie Lehrke, Ramesh Mazhari, Daniel J Durand, et al.
Journal of Neurosurgery. Pediatrics
|
April 6, 2019
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report
Matthew D Hall, Yazmin Odia, Joshua E Allen, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
International Journal of Cancer
|
August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Shinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Jaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Journal of Neuropathology and Experimental Neurology
|
June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment
Fares Nigim, Jill Cavanaugh, Anoop P Patel, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
Neuro-Oncology
|
February 18, 2020
"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas
Rajan Jain, Derek R Johnson, Sohil H Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor
Andrew S Chi, Tracy T Batchelor, Eunice L Kwak, et al.
Journal of Neuro-Oncology
|
November 5, 2015
Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
Brian V Nahed, Navid Redjal, Daniel J Brat, et al.
Circulation Research
|
July 29, 2006
Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling
Stephanie Lehrke, Ramesh Mazhari, Daniel J Durand, et al.
Journal of Neurosurgery. Pediatrics
|
April 6, 2019
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report
Matthew D Hall, Yazmin Odia, Joshua E Allen, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
International Journal of Cancer
|
August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Shinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Jaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Journal of Neuropathology and Experimental Neurology
|
June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment
Fares Nigim, Jill Cavanaugh, Anoop P Patel, et al.
Page
of 9